BioXcel Therapeutics, Inc. (BTAI)
Pharmaceutical Preparations
Latest Price
$0.07
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
0.20
P/B Ratio
0.37
Institutional Ownership
19.7% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| MILLENNIUM MANAGEMENT LLC | 2.11M | $2.0M | 6.76% | +177.9K | 2026-06-30 |
| OAKTREE CAPITAL MANAGEMENT LP | 1.38M | $1.0M | 4.41% | +1.14M | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 919.5K | $1.0M | 2.94% | +712.2K | 2026-06-30 |
| Oaktree Fund Advisors, LLC | 245.6K | -- | 0.78% | +202.7K | 2026-06-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 242.3K | -- | 0.77% | +12.1K | 2026-06-30 |
| BlackRock, Inc. | 179.4K | -- | 0.57% | +95.2K | 2026-06-30 |
| UBS Group AG | 158.1K | -- | 0.50% | +105.3K | 2026-06-30 |
| CITADEL ADVISORS LLC | 149.2K | -- | 0.48% | +137.8K | 2026-06-30 |
| VANGUARD FIDUCIARY TRUST CO | 136.9K | -- | 0.44% | +52.0K | 2026-06-30 |
| STATE STREET CORP | 92.1K | -- | 0.29% | -- | 2026-06-30 |